Simplex Trading
NMTC icon

Simplex Trading’s NeuroOne Medical Technologies NMTC Stock Holding History

Simplex Trading’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.27K Buy
+917
New +$4.41K ﹤0.01% 7992
2025
Q4 		– Sell
-1,800
Closed -$9K – 9565
2025
Q3 		$9K Buy
1,800
+1,383
+332% +$6.77K ﹤0.01% 7974
2025
Q2 		$1K Buy
417
+84
+25% +$310 ﹤0.01% 8380
2025
Q1 		$1K Buy
+333
New +$2.11K ﹤0.01% 8259
2023
Q1 		– Sell
-200
Closed -$1K – 9774
2022
Q4 		$1K Buy
200
+33
+20% +$295 ﹤0.01% 8870
2022
Q3 		$1K Buy
+167
New +$1.59K ﹤0.01% 9589

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Simplex Trading's NMTC Position: Q4 2025 in Review

Simplex Trading sold out of NeuroOne Medical Technologies (NMTC) in Q4 2025, closing a stake of 2,241 shares — an estimated $11K sold.

Simplex Trading first reported a position in NMTC in Q4 2022 and held it in 8 quarters. The position peaked at $11K in Q3 2025. 37 funds tracked by Wall St. Rank hold NMTC as of Q4 2025.

  • Simplex Trading reported no remaining NeuroOne Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 2,241 NeuroOne Medical Technologies shares in Q4 2025, an estimated $11K.
  • Simplex Trading first reported a position in NeuroOne Medical Technologies in Q4 2022 and held it in 8 quarters.
  • Simplex Trading's NeuroOne Medical Technologies position peaked at $11K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.